Your browser doesn't support javascript.
loading
Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease.
Ter Veer, Emil; van Rijssen, L Bengt; Besselink, Marc G; Mali, Rosa M A; Berlin, Jordan D; Boeck, Stefan; Bonnetain, Franck; Chau, Ian; Conroy, Thierry; Van Cutsem, Eric; Deplanque, Gael; Friess, Helmut; Glimelius, Bengt; Goldstein, David; Herrmann, Richard; Labianca, Roberto; Van Laethem, Jean-Luc; Macarulla, Teresa; van der Meer, Jonathan H M; Neoptolemos, John P; Okusaka, Takuji; O'Reilly, Eileen M; Pelzer, Uwe; Philip, Philip A; van der Poel, Marcel J; Reni, Michele; Scheithauer, Werner; Siveke, Jens T; Verslype, Chris; Busch, Olivier R; Wilmink, Johanna W; van Oijen, Martijn G H; van Laarhoven, Hanneke W M.
Affiliation
  • Ter Veer E; Department of Medical Oncology, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, Netherlands.
  • van Rijssen LB; Department of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, Netherlands.
  • Besselink MG; Department of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, Netherlands.
  • Mali RMA; Department of Medical Oncology, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, Netherlands.
  • Berlin JD; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA.
  • Boeck S; Department of Internal Medicine III, Comprehensive Cancer Center, Klinikum Grosshadern, Ludwig-Maximilians-University of Munich, Munich, Germany.
  • Bonnetain F; Methodology and Quality of Life in Oncology Unit, University Hospital of Besançon, Besançon, France.
  • Chau I; Royal Marsden NHS Foundation Trust, London and Surrey, UK.
  • Conroy T; Department of Medical Oncology, Institut de Cancérologie de Lorraine and Lorraine University, Vandoeuvre-lès-Nancy, France.
  • Van Cutsem E; Department of Gastroenterology and Digestive Oncology, University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium.
  • Deplanque G; Department of Oncology, Hôpital Riviera-Chablais, Vevey, Switzerland.
  • Friess H; Department of Surgery, Technical University of Munich, Klinikum rechts der Isar, Munich, Germany.
  • Glimelius B; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Goldstein D; Nelune Cancer Centre, Prince of Wales Hospital, Prince of Wales Clinical School University of New South Wales, Randwick, NSW, Australia.
  • Herrmann R; Department of Medical Oncology, University Hospital Basel, Basel, Switzerland.
  • Labianca R; Cancer Center, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Van Laethem JL; Department of Gastroenterology, Gastrointestinal Cancer Unit, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
  • Macarulla T; Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • van der Meer JHM; Department of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, Netherlands.
  • Neoptolemos JP; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
  • Okusaka T; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • O'Reilly EM; Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA.
  • Pelzer U; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute of Health, Berlin, Germany.
  • Philip PA; Department of Oncology, Karmanos Cancer Center, Wayne State University, Detroit, MI, USA.
  • van der Poel MJ; Department of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, Netherlands.
  • Reni M; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Scheithauer W; Department of Internal Medicine I, Medical University Vienna, Vienna, Austria.
  • Siveke JT; Division of Solid Tumor Translational Oncology, West German Cancer Cancer, University Hospital Essen, Essen, Germany; German Cancer Consortium (DKTK, partner site Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany.
  • Verslype C; Department of Digestive Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Busch OR; Department of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, Netherlands.
  • Wilmink JW; Department of Medical Oncology, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, Netherlands.
  • van Oijen MGH; Department of Medical Oncology, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, Netherlands.
  • van Laarhoven HWM; Department of Medical Oncology, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, Netherlands. Electronic address: h.vanlaarhoven@amc.uva.nl.
Lancet Oncol ; 19(3): e151-e160, 2018 03.
Article de En | MEDLINE | ID: mdl-29508762

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du pancréas / Plan de recherche / Essais contrôlés randomisés comme sujet / Essais cliniques de phase III comme sujet / Exactitude des données Type d'étude: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Aspects: Patient_preference Limites: Humans Langue: En Journal: Lancet Oncol Sujet du journal: NEOPLASIAS Année: 2018 Type de document: Article Pays d'affiliation: Pays-Bas

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du pancréas / Plan de recherche / Essais contrôlés randomisés comme sujet / Essais cliniques de phase III comme sujet / Exactitude des données Type d'étude: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Aspects: Patient_preference Limites: Humans Langue: En Journal: Lancet Oncol Sujet du journal: NEOPLASIAS Année: 2018 Type de document: Article Pays d'affiliation: Pays-Bas